Zhejiang Taimei Medical Technology Co (HKSE:02576) Construction In Progress: HK$0.0 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02576 Zhejiang Taimei Medical Technology Co Ltd HKSE:02576
11 GF Score
Price HK$5.72
! 4 Warning Signs
View Full Analysis

What is Zhejiang Taimei Medical Technology Co Construction In Progress?

Zhejiang Taimei Medical Technology Co HKSE:02576 +1.96% 11 Construction In Progress is HK$0.0 Mil as of Dec. 2025. GuruFocus rates HKSE:02576 with a GF Score™ of 11/100. The stock has 4 warning signs investors should review.

Zhejiang Taimei Medical Technology Co's annual construction in progress declined from Dec. 2023 (HK$0.0 Mil) to Dec. 2024 (HK$0.0 Mil) but then stayed the same from Dec. 2024 (HK$0.0 Mil) to Dec. 2025 (HK$0.0 Mil).

Zhejiang Taimei Medical Technology Co Construction In Progress Historical Data

* Premium members only.

The historical data trend for Zhejiang Taimei Medical Technology Co's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhejiang Taimei Medical Technology Co Construction In Progress Chart

Zhejiang Taimei Medical Technology Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Construction In Progress
12.36 0.81 0.04 0.00 0.00

Zhejiang Taimei Medical Technology Co Semi-Annual Data
Dec21 Dec22 Dec23 Jun24 Dec24 Jun25 Dec25
Construction In Progress Get a 7-Day Free Trial 0.04 0.00 0.00 0.00 0.00
HKSE:02576
11GF Score
Zhejiang Taimei Medical Technology Co Ltd HKSE:02576
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zhejiang Taimei Medical Technology Co Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of HK$0.0 Mil mean?
Zhejiang Taimei Medical Technology Co (HKSE:02576) has a Construction In Progress of HK$0.0 Mil as of Dec. 2025. Construction in Progress records the amount of construction work that is not complete. View historical data on Zhejiang Taimei Medical Technology Co and its competitors.
Is Zhejiang Taimei Medical Technology Co's Construction In Progress too high?
Zhejiang Taimei Medical Technology Co's current Construction In Progress is HK$0.0 Mil. Overall, Zhejiang Taimei Medical Technology Co has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Taimei Medical Technology Co's Construction In Progress compare to VEEV and BTSG?
Zhejiang Taimei Medical Technology Co's Construction In Progress of HK$0.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Healthcare Providers & Services company?
A good Construction In Progress depends on the Healthcare Providers & Services industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Zhejiang Taimei Medical Technology Co and its competitors. Zhejiang Taimei Medical Technology Co's current Construction In Progress is HK$0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Taimei Medical Technology Co stock overvalued right now?
Zhejiang Taimei Medical Technology Co (HKSE:02576) has a current Construction In Progress of HK$0.0 Mil. The current Construction In Progress is HK$0.0 Mil. Zhejiang Taimei Medical Technology Co's overall GF Score™ is 11/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Zhejiang Taimei Medical Technology Co (HKSE:02576), the current Construction In Progress is HK$0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Zhejiang Taimei Medical Technology Co Business Description

Address 36 Changsheng South Road, 3rd Floor, Building 9, Smart Industry Innovation Park, Zhejiang Province, Jiaxing, CHN
Zhejiang Taimei Medical Technology Co Ltd is a digital solution provider focused on the pharmaceutical and medical device industry in China. It designs and delivers industry-specific software and digital services that facilitate research and development (R&D) and the commercialization of pharmaceuticals and medical devices. The software it offers is cloud-based, allowing users to access it from various devices at any time over the internet, without the need for software installation and maintenance on their devices. It has a geographical presence in Mainland China, the United States, Singapore, Korea, and Others.
11GF Score

Get the complete analysis for HKSE:02576

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$5.72
Price